Funded projects: In 2022 the MFM group obtained three new funded projects (1 AES-ISCIII, 1 Convocatoria Proyectos de Colaboración Público-Privada-Ministerio de Ciencia e Innovación, 1 PERIS-Departament de Salut-Generalitat de Catalunya). Dissemination of results: The group has published 28 scientific articles, 5 in the first decile, 8 in the first quartile, 4 in the second quartile, 6 in the third quartile and 4 in the fourth quartile.
Four doctoral theses were presented by Dr Alba Farràs, Mireia Vargas, Maddalena Santirocco and Edgar Coello, respectively. Fourty-four communications have been presented in 28 (64%) national and 16 (26%) international congresses: 25 as invited speakers, 13 oral communications and six posters. Networking: Vall d’Hebron Hospital has been actively working at the ERN Ithaca, participating in two workshops. The MFM group is actively working in the Spina bifida group.
Group Leader
Elena Carreras Moratonas
Principal Investigator (PI)
Anna Suy, María Goya, Nerea Maiz, Carlota Rodó, María Ángeles Sánchez-Durán, Melchor Carbonell, Maia Brik
Researchers
Maria Teresa Higueras, Alba Farràs Llobet, Julio Herrero, Susana Manrique, Vanessa Bueno
PhD Students
Silvia Arévalo, Itziar García Ruiz, Francisco Barranco, Erika Bonacina, Paula García Aguilar, Giula Mackina, Lidia Illan, Marta Miserachs, María Luisa Pancorbo, María Antonia Perelló, Inés Calero, Berta Serrano
25
PUBLICATIONS
60.0%
%Q1
139
IMPACT FACTOR
5.54
AVERAGE IMPACT FACTOR
SELECTED ARTICLES
Bonacina E, Mendoza M, Farras A, Garcia-Manau P, Serrano B, Hurtado I, Ferrer-Oliveras R, Illan L, Armengol M, Carreras E
Angiogenic factors for planning fetal surveillance in fetal growth restriction and small-for-gestational-age fetuses: a prospective observational study
BJOG 2022;129(11):1870-1877
DOI: doi: 10.1111/1471-0528.17151
IF: 6.531
Mendoza M, Bonacina E, Serrano B, Ricart M, Martin L, Lopez-Quesada E, Vives A, Maroto A, Garcia-Manau P, De Antonio C, Tusquets C, Moreano G, Armengol M, Carreras E
Implementation of routine first-trimester combined screening for preeclampsia based on the Gaussian algorithm: a clinical effectiveness study
Int J Gynaecol Obstet 2022; 159(3):803-809
DOI: doi: 10.1002/ijgo.14192
IF: 3.282
Serrano B, Mendoza M, Garcia-Aguilar P, Bonacina E, Garcia-Ruiz I, Garcia-Manau P, Gil J, Armengol-Alsina M, Fernandez-Hidalgo N, Sulleiro E, Lopez-Martinez RM, Ricart M, Martin L, Lopez-Quesada E, Vives A, Maroto A, Maiz N, Suy A, Carreras E
Shared risk factors for COVID-19 and preeclampsia in the first trimester: An observational study
Acta Obstet Gynecol Scand 2022;101(7):803-808
DOI: doi: 10.1111/aogs.14371
IF: 4.544
Vargas M, Yañez F, Elias A, Bernabeu A, Goya M, Xie Z, Farrás A, Sánchez O, Soler Z, Blasquez C, Valle L, Olivella A, Muñoz B, Brik M, Carreras E, Manichanh C
Cervical pessary and cerclage placement for preterm birth prevention and cervicovaginal microbiome changes
Acta Obstet Gynecol Scand. 2022;101(12):1403-1413
DOI: doi: 10.1111/aogs.14460
IF: 4.544
Brik M, Sandonis M, Gil J, Hernandez-Fleury A, Parramón-Puig G, Maiz N, Suy A, Carreras E
Intrauterine cannabis exposure and fetal and maternal blood flow: a case-control study
Acta Obstet Gynecol Scand. 2022;101(11):1207-1214
DOI: doi: 10.1111/aogs.14439
IF: 4.544
Ingeniería tisular para la mejora de la técnica quirúrgica de la reparación fetoscópica de los defectos de tubo neural espinales en fetos ovinos (TISSUE-NTD)
Principal Investigator: Nerea Maiz
Agency: ISCIII
Funding: 135,520€
Period: 2021-2023
NUEVAS ESTRATEGIAS ANTIOXIDANTES PARA EL TRATAMIENTO MULTIMODAL DE LA PREECLAMPSIA (AFRODITA)
Principal Investigator: Elena Carreras
Agency: ISCIII
Funding: 111,320€
Period: 2021-2023
Programa de cribratje universal de CMV al primer trimestre de l’embaràs: estudi pilot multicentril a l’area de Barcelona (ESTUDI CITEMB)
Principal Investigator: María Ángeles Sánchez
Agency: Departament de Sanitat de la Generalitat de Catalunya
Funding: 189,794.91€
Period: 2022-2024
SCREENING FOR PREECLAMPSIA IN TWIN PREGNANCIES (PRESC-TWIN)
Principal Investigator: Carlota Rodó
Agency: Instituto de Salud Carlos III
Funding: 162,140€
Period: 2022-2024
Impact of COVID-19 on male reproductive health
Principal Investigator: Melchor Carbonell
Agency: Fundació La Marató TV3
Funding: 399,821€
Period: 2022-2024
eCOREs
